Insider Transactions in Q3 2022 at Ovid Therapeutics Inc. (OVID)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 12
2022
|
Jason Tardio Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
17,344
-100.0%
|
$34,688
$2.15 P/Share
|
|
Jul 01
2022
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
5,750,000
+50.0%
|
-
|
|
Jul 01
2022
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
5,750,000
-100.0%
|
-
|